CGBIO_ID
CGBIO
Menu
  • Tentang CGBio
    • Perkenalan
    • Sambutan CEO
    • Sejarah Bisnis
    • Divisi Bisnis Global
    • Sejarah
  • Research and Development
    • Perkenalan Pusat Riset
    • Bidang Penelitian
    • Sertifikat dan patent
    • Publikasi Tesis
  • Informasi Produk
    • Keseluruhan
    • Ortopedi
    • Penyembuhan Luka
    • Estetik
    • Dental
  • ID
    • KOR
    • ENG
    • CN
    • JP
    • TH
    • ES
Open
Close
Sitemap
시지바이오 사이트맵 닫기
Tentang CGBio
Perkenalan
Sambutan CEO
Sejarah Bisnis
Divisi Bisnis Global
Sejarah
Research and
Development
Perkenalan Pusat Riset
Bidang Penelitian
Sertifikat dan patent
Publikasi Tesis
Informasi
Produk
Keseluruhan
Ortopedi
  • NOVOSIS
  • MEDICLORE
  • Bongener
  • Excelos Inject
  • Lumfix
  • NOVOMAX
Penyembuhan Luka
  • CURAVAC
  • CuraVAC SILVER
  • Curasys
  • EASYFOAM
  • EASYDERM PLUS THIN
  • EASYEF
Estetik
  • Cellunit
Dental
  • Novosis Dent
  • Bongener
  • Bongros
  • ExcelOS Inject
home

R & D

Wound

  • Perkenalan Pusat Riset
  • Bidang Penelitian
  • Sertifikat dan patent
  • Publikasi Tesis
Research Info
Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing
  • 2015-03-19
  • cgbio
  • 조회수Views : 1,113 views

Kim YS, Lew DH, Tark KC, Rah DK, Hong JP.

Effect of recombinant human epidermal growth factor against cutaneous scar formation in murine full-thickness wound healing. Journal of Korean medical science 2010; 25(4): 589-96.

wound5

NEXT
The prediction and prevention of laser-induced post-inflammatory hyperpigmentation
PREV
The use of recombinant human epidermal growth factor(rh-EGF, Nepidermin) to minimize scar formation
LIST

Head Office : F3, 211, Itaewon-ro, Yongsan-gu, Seoul, Korea
Research Institute : 244, Galmachi-ro,Jungwon-gu,Seongnam-si, Gyeonggi-do,Korea
Head Office TEL. +82-2-550-8300

Copyright All Right Reserverd By CGbio

인스타그램 페이스북

  • Family site
    • DaewoongPhamercy
    • Daewoong Bio
    • DNC
    • Bio-Alpha

to be updated.

OK close